Atlas Genetics Ltd:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Atlas Genetics Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7447
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Atlas Genetics Ltd (Atlas Genetics) is an in vitro diagnostics company that offers decentralised, near-patient and point of care testing services. The company develops and offers diagnostic platforms such as io system and callisto system. Its io system is a diagnostic instrument and disposable cartridge system, which is designed for POC testing services to provide accurate solution to screening for the presence of STIs and HAIs. The company’s products and solutions are used in the diagnosis of sexually transmitted infections, neonatal sepsis, and hospital acquired infection. It serves clinicians and other healthcare professionals. The company operates in the US and the UK. Atlas Genetics is headquartered in Trowbridge, the UK.

Atlas Genetics Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Atlas Genetics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Atlas Genetics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Atlas Genetics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Atlas Genetics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Atlas Genetics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Atlas Genetics Ltd, Medical Equipment, Deal Details 10
Venture Financing 10
Atlas Genetics Raises USD35 Million in Series D Financing 10
Atlas Genetics Raises USD20 Million in Series C Financing 12
Partnerships 14
Atlas Genetics Enters into Agreement with Pharma Company 14
Atlas Genetics Ltd – Key Competitors 15
Atlas Genetics Ltd – Key Employees 16
Atlas Genetics Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Jan 05, 2018: Life Sciences Pioneer Stanley Lapidus Joins Atlas Genetics Board of Directors 18
Dec 12, 2017: Atlas Genetics Expands Executive Team, Appointing Marc Jones as Chief Operating Officer and Chief Financial Officer 19
Oct 03, 2017: Atlas Genetics Appoints Life Sciences Veteran, Jeffrey Luber, as Chief Executive Officer; Founding CEO Dr John Clarkson Steps Up to Executive Chairman 20
Oct 03, 2017: Atlas Genetics Appoints Life Sciences Veteran, Jeffrey Luber, as Chief Executive Officer; Founding CEO Dr John Clarkson Steps Up to Executive Chairman 21
Legal and Regulatory 22
Oct 08, 2018: Atlas Genetics announces company rebranding, changes name to Binx Health 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Atlas Genetics Ltd, Medical Equipment, Key Facts 2
Atlas Genetics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Atlas Genetics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Atlas Genetics Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Atlas Genetics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Atlas Genetics Ltd, Deals By Market, 2012 to YTD 2018 8
Atlas Genetics Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Atlas Genetics Raises USD35 Million in Series D Financing 10
Atlas Genetics Raises USD20 Million in Series C Financing 12
Atlas Genetics Enters into Agreement with Pharma Company 14
Atlas Genetics Ltd, Key Competitors 15
Atlas Genetics Ltd, Key Employees 16
Atlas Genetics Ltd, Other Locations 17

List of Figures
Atlas Genetics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Atlas Genetics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Atlas Genetics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Atlas Genetics Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Atlas Genetics Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Atlas Genetics Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Atlas Genetics Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Atlas Genetics Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Atlas Genetics Ltd:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Challenge Group Holdings PTE. LTD.:企業の戦略・SWOT・財務情報
    Challenge Group Holdings PTE. LTD. - Strategy, SWOT and Corporate Finance Report Summary Challenge Group Holdings PTE. LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Elsalys Biotech SAS-製薬・医療分野:企業M&A・提携分析
    Summary Elsalys Biotech SAS (Elsalys Biotech) is a biotechnology company that designs and develops therapeutic antibodies in oncology and ophthalmology. The company's pipeline products include monoclonal antibodies designed to fight against cancers, vascular eye, idiopathic pulmonary fibrosis and ch …
  • Energy Metals Ltd (EME):企業の財務・戦略的SWOT分析
    Summary Energy Metals Ltd (Energy Metals) is a mining and mineral exploration company that focuses on the development of mineral resources in Australia. It acquires, explores, operates, manages, produces, and develops uranium, vanadium, and mineral resource deposit properties. Energy Metals' project …
  • Total SA (FP)-石油・ガス分野:企業M&A・提携分析
    Summary Total S.A. (Total) is an integrated global oil and gas company that produces, refines and markets oil, and also manufactures petrochemicals. It carries out drilling, oil and gas production, processing, transportation, refining and petrochemical production, storage and distribution of petrole …
  • Xerox Corporation:企業の戦略・SWOT・財務情報
    Xerox Corporation - Strategy, SWOT and Corporate Finance Report Summary Xerox Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ultragenyx Pharmaceutical Inc (RARE):医療機器:M&Aディール及び事業提携情報
    Summary Ultragenyx Pharmaceutical Inc (Ultragenyx) is a biotechnology company that develops life-enhancing therapeutics for rare and ultra-rare genetic diseases. Its only marketed product, Mepsevii (vestronidase alfa) is the first indication approved for the treatment of adults and children with Muc …
  • Century Aluminum Co:企業の戦略・SWOT・財務分析
    Century Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Century Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • China National Chemical Engineering Co., Ltd:企業の戦略・SWOT・財務情報
    China National Chemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary China National Chemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Dong-A Socio Holdings Co Ltd (000640):製薬・医療:M&Aディール及び事業提携情報
    Summary Dong-A Socio Holdings Co Ltd (Dong-A Socio Holdings), formerly Dong-A Pharmaceutical Co., Ltd., offers business management services. It is a subsidiary of Dong-A Socio Group. It operates in various markets such as pharmaceuticals, food and beverages, logistics, IT, and materials. The group f …
  • Pegasystems Inc (PEGA):企業の財務・戦略的SWOT分析
    Pegasystems Inc (PEGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Rebiotix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rebiotix Inc (Rebiotix), formerly MikrobEX Inc is a clinical stage biotechnology company that develops treatments for debilitating diseases. The company targets various disease conditions using drugs based on its microbiota restoration therapy platform. It lead product candidate RBX2660 is u …
  • Erasmus MC-製薬・医療分野:企業M&A・提携分析
    Summary Erasmus MC (Erasmus) is a medical institute that offers patient care, research and educational services. The institute offers graduate and doctoral programs in health sciences, biomedical sciences, molecular medicine and cardiovascular sciences. It conducts research in the areas of biochemis …
  • Santos Ltd (STO):石油・ガス:M&Aディール及び事業提携情報
    Summary Santos Ltd (Santos) is an independent oil and natural gas company. Its activities include onshore, offshore and liquefied natural gas (LNG) projects. The company has exploration and production acreage in Australia and Papua New Guinea. Its core natural gas assets include Cooper Basin, Queens …
  • Avon Rubber Plc (AVON):企業の財務・戦略的SWOT分析
    Avon Rubber Plc (AVON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • China Shineway Pharmaceutical Group Ltd (2877):企業の財務・戦略的SWOT分析
    Summary China Shineway Pharmaceutical Group Ltd (China Shineway) is a pharmaceutical company that offers development, manufacture and sales of Chinese medicines. The company’s products comprise shenmai injection, qingkailing injection, huangqi injection, shuxiening injection, wufu xinnaoqing soft ca …
  • Brooks MacDonald Group PLC (BRK):企業の財務・戦略的SWOT分析
    Brooks MacDonald Group PLC (BRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • IMV Inc (IMV):製薬・医療:M&Aディール及び事業提携情報
    Summary IMV Inc (IMV), formerly Immunovaccine Inc, is a clinical-stage biopharmaceutical company that develops cancer immunotherapies and infectious disease vaccines. The company’s product candidates include DPX-Survivac, a T cell activating immunotherapy that identifies and disrupts cancer biology …
  • Netsmart Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary Netsmart Technologies Inc (Netsmart) is a subsidiary of GI Partner, is a provider of enterprise software solutions for health and human services providers and payers. It provides on-demand and on-premise software solutions to automate major financial, clinical and management processes to its …
  • China Shenhua Energy Co Ltd:戦略・SWOT・企業財務分析
    China Shenhua Energy Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Shenhua Energy Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Putzmeister Holding GmbH:企業の戦略・SWOT・財務情報
    Putzmeister Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Putzmeister Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆